Bicycle Therapeutics
NasdaqGS:BCYC
$ 4,68
+ $0,18 (4,00%)
4,68 $
+$0,18 (4,00%)
End-of-day quote: 03/25/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-2,96
Earnings Per Share
$0,51
Revenue Per Share
0,00%
Gross Margin %
$0,31 B
Market Cap
$0,03 B
Long-Term Debt
Earnings Per Share
$-2,96
Revenue Per Share
$0,51
Gross Margin %
0,00%
Market Cap
$0,31 B
Long-Term Debt
$0,03 B

Financials

Year Year 2026 2024 2023 2022 2021 2020 2019 2018
EPS Earnings Per Share $-2,96 $-5,08 $-3,80 $-2,67 $-2,66 $-2,77 $-49,78
Earnings Earnings $-204,83M $-216,36M $-114,08M $-79,03M $-61,42M $-49,83M $-41,82M
RPS Revenue Per Share $0,00 $0,51 $0,63 $0,48 $0,40 $0,45 $0,77 $8,50
Revenue Revenue $0,00M $35,28M $26,98M $14,46M $11,70M $10,39M $13,80M $7,14M
OCF Operating Cash Flow $0,00M $-164,72M $-60,63M $-86,11M $-14,79M $-17,79M $-28,61M $0,00M
FCF Free Cash Flow $0,00M $-165,96M $-63,56M $-105,10M $-16,82M $-18,99M $-30,17M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00% 0,00% -190,56% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% -283,69% -219,05% -85,06% -190,93%
FCFS Free Cash Flow Per Share $0,00 $-2,85 $-1,79 $-3,54 $-0,67 $-0,99 $-2,73 $-62,12
LT Debt Long-Term Debt N/A N/A $30,70M $30,32M $29,87M $14,51M N/A N/A
Sha. Stocks 69,2M 69,2M 42,59M 30,02M 29,6M 23,09M 17,99M 0,84M
×